Integer appoints Michael Coyle to Board; brings 40+ years medtech leadership

Integer Holdings Corp

Michael Coyle appointed to Integer's Board of Directors effective July 10, 2025.
Coyle most recently served as president/CEO of iRhythm Technologies; prior roles at Medtronic, St. Jude Medical, and Eli Lilly.
He will serve on Audit, Compensation & Organization, and Technology Strategy Committees.
Board size increased to 11 directors; Coyle's term runs until next annual meeting.
Coyle holds a Wharton MBA and six U.S. patents related to cardiovascular medical devices.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.